Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Celsius Holdings shares fell 5.2% in pre-open trading after Deutsche Bank moved its rating from Buy to Hold while raising the price target to $35 from $30. The change reflects a view that risk-reward near current levels is less attractive, coming after Q2 2026 results that showed a decline in core brand revenue, a miss on adjusted EPS and sharply c…
Biomerica, Inc., a Nasdaq-listed biomedical diagnostics company, announced a $2.23 million private placement priced at $1.60 per share with participation from B. Riley Principal Capital, company executives, and board members. The proceeds will bolster the company's financial position, support ongoing operations, and facilitate evaluation of strateg…
Our Bond, Inc., an AI-powered preventative personal security platform company, has signed a definitive agreement with the City of Jerusalem to provide security services to approximately 10,000 municipal employees. This follows a successful pilot and solidifies Bond's government-to-consumer growth strategy. The deal highlights the scalability and ef…
TransUnion's new analysis finds consumers enrolling in third-party debt settlement programs experience greater credit score declines than bankruptcy filers. Nearly half of enrollees were current on payments prior to enrollment. Combining bankruptcy-related signals with credit trend data improves identification of consumers likely to enter debt sett…
ZenaTech, Inc. announced that its subsidiary ZenaDrone has won the 'Drone Technology of the Year' award by the AgTech Breakthrough Awards for its AI-powered drones advancing precision agriculture. Their drone solutions, currently in testing and pilot stages, assist farmers in early crop stress detection, precise irrigation, fertilizer application, …
Callan JMB Inc., through its subsidiary Callan Power LLC, announced the acquisition of non-operated working interest in 377 producing oil and gas wells and additional 27 wells in process across the Williston Basin for $12.5 million in cash. The assets have an independently estimated proved PV-10 value of approximately $48 million and total 3P PV-10…
Quanta Services (PWR) has been hit by a rapid derating from its 2026 highs. The selloff creates a favorable risk-reward: the company sports a near-record backlog, healthy free cash flow and shareholder-friendly actions, while valuation and sentiment have pulled back enough to justify a tactical long. This trade idea lays out an entry at $620.00, a …
Synopsys is the core EDA and IP provider quietly baked into the chip design flows that power next-generation AI chips. With a $78.5B market cap, $2.75B in free cash flow and partnership momentum around agentic engineering toolkits, the stock looks like a tactical buy on strength in design automation demand. This trade plan buys the stock near curre…
GSK ($51.44) combines a resilient commercial franchise, meaningful vaccine exposure and a mid-teens P/E with a 3.4% yield. Technicals are neutral-to-bullish and the company sits squarely in expanding vaccine markets (influenza, HPV). I recommend a long trade sized for a diversified portfolio: entry $51.40, primary target $62.00, stop loss $48.00, h…
AZIO AI Holdings, Inc. has expanded its agreement with Power Champion Investment Limited to potentially provide up to 512 NVIDIA HGX B300 GPU systems, increasing the estimated sales pipeline value to approximately $307 million. This expansion follows the company's announcement of Atlas One, a South Texas AI compute infrastructure campus engineered …
BranchOut Food Inc. has priced an underwritten public offering of 820,588 shares at $3.40 per share, aiming to raise approximately $2.79 million in gross proceeds. The funds will be used for working capital and general corporate purposes. The offering is expected to close on or about August 28, 2026.
Harmony Biosciences Holdings, Inc., a pharmaceutical company focused on rare neurological diseases, announced that its management team will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on September 10, 2026, with a webcast available to investors.
BranchOut Food Inc. announced initial commercial orders totaling approximately $750,000 for its new front-of-club Crunchy Fruit Chip Multipack Product Line and shelf-stable Dried Cheesecake Bites with the nation’s largest warehouse club retailer. The multipack line is set for launch in Mexico, marking the company's first international warehouse clu…
Catheter Precision, Inc. announced key commercial milestones including its first purchase order through Cardinal Health, an extensive U.S. healthcare distributor, and the first order from Johns Hopkins Hospital for its LockeT suture retention device. Additionally, the company has placed its VIVO 3D Imaging System with a hospital in Germany, marking…
Nasdaq Verafin announced a partnership with Q6 Cyber to integrate dark web fraud intelligence into its financial crime management platform. This alliance aims to provide financial institutions with early alerts on compromised accounts and payment methods, allowing proactive fraud prevention prior to fraudulent transactions. The combined data from Q…
Expion Energy, Inc., a Nasdaq-listed company known for its lithium battery technology, appointed Robert Winspear as Chief Financial Officer, signaling a strategic focus on entering the oil and gas sector alongside its established battery business. Winspear brings extensive capital markets and M&A experience, supporting the company's growth plans an…
Alvotech, a global biotechnology company specializing in biosimilar medicines, announced that its Founder and Chairman, Robert Wessman, and Chief Strategy Officer, Dr. Balaji V. Prasad, will participate in upcoming investor conferences hosted by Morgan Stanley and Deutsche Bank in September 2026. These events include a fireside chat and investor me…
ChronoScale Corporation announced a partnership with Microsoft to deploy a 50-megawatt AI compute infrastructure in North America. The deployment will utilize NVIDIA GB300 NVL72 systems coupled with advanced liquid-cooling technology to support high-density AI workloads. This full-stack infrastructure is designed to meet the power, cooling, network…
Entera Bio Ltd., a clinical stage biotechnology company specializing in oral peptide therapies, announced its CEO Miranda Toledano will participate in several prominent healthcare investor conferences throughout fall 2026. The company highlighted its proprietary N-Tab technology platform and diverse pipeline including its leading osteoporosis candi…
Genius Group Limited announced a $1.2 billion capital plan to fund its dual treasury strategy targeting $800 million in AI assets and $827 million in Bitcoin assets by fiscal year 2031. The company will issue perpetual preferred securities to raise capital without diluting ordinary shareholders, aiming to maximize net asset value per share (NAVPS).…
Apollo Global Management and KKR have partnered strategically with Apollo acquiring a significant interest in Atlantic Aviation, a leading U.S. private aviation infrastructure provider valued at nearly $10 billion. The partnership aims to leverage Atlantic Aviation's extensive airport infrastructure and long-term concessions to capture growth oppor…
Pluri Inc., a biotechnology company operating in the human health and FoodTech sectors, has priced a $3.3 million registered direct offering, including the sale of 2,228,940 common shares to a single healthcare-focused institutional investor at $1.50 per share. Concurrently, the company will issue unregistered warrants exercisable at $1.65 per shar…
Verrica Pharmaceuticals has announced the completion of patient enrollment in the first pivotal Phase 3 trial (COVE-2) evaluating YCANTH® (VP-102) for common warts treatment, with topline data expected in the first quarter of 2027. The company is on track with its global Phase 3 program, which also includes a second trial (COVE-3) over 50% enrolled…
Rank One Computing Corporation (ROC) has won a significant five-year contract valued at $5.1 million to supply its multimodal automated biometric identification system (ABIS) to a major federal national security program. This contract marks a strategic breakthrough for ROC in the U.S. federal biometrics market, establishing a foundational customer …
MBX Biosciences has dosed the first patient in its pivotal Phase 3 oPTimize trial evaluating once-weekly canvuparatide for chronic hypoparathyroidism treatment. Building on positive Phase 2 results, the global trial aims to demonstrate the drug's efficacy and safety as a potential best-in-class parathyroid hormone replacement therapy. This mileston…
